UNIV OSLO HF has a total of 271 patent applications. It decreased the IP activity by 31.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are NAT CANCER CT, 2ND AFFILIATED HOSPITAL NANJING MEDICAL UNIV and DKFZ KREBSFORSCHUNGSZENTRUM.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 74 | |
#2 | EPO (European Patent Office) | 55 | |
#3 | United States | 50 | |
#4 | United Kingdom | 38 | |
#5 | Canada | 17 | |
#6 | China | 8 | |
#7 | Australia | 7 | |
#8 | Republic of Korea | 7 | |
#9 | Japan | 3 | |
#10 | Brazil | 2 | |
#11 | Israel | 2 | |
#12 | Mexico | 2 | |
#13 | Singapore | 2 | |
#14 | Chile | 1 | |
#15 | Hong Kong | 1 | |
#16 | India | 1 | |
#17 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Telecommunications | |
#6 | Computer technology | |
#7 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Therapeutic chemical compounds | |
#6 | Analysing materials | |
#7 | Diagnosis and surgery | |
#8 | Antennas | |
#9 | Heterocyclic compounds | |
#10 | Image data processing |
# | Name | Total Patents |
---|---|---|
#1 | Lothe Ragnhild A | 35 |
#2 | Kvalheim Gunnar | 29 |
#3 | Inderberg Else Marit | 25 |
#4 | Lind Guro E | 25 |
#5 | Gaudernack Gustav | 24 |
#6 | Skotheim Rolf I | 20 |
#7 | Walchli Sebastien | 17 |
#8 | Lind Guro Elisabeth | 14 |
#9 | Klungland Arne | 14 |
#10 | Wälchli Sébastien | 14 |
Publication | Filing date | Title |
---|---|---|
GB202015584D0 | Treatment for viral infection | |
WO2021048337A1 | System and method for communication among multi-chamber leadless pacemaker devices | |
GB202010359D0 | Compounds | |
GB202004075D0 | Anti-steap1 car | |
WO2020127734A1 | Chimeric antigen receptors (cars) and their use in medicine | |
WO2020099938A2 | Methods and compositions for characterizing bladder cancer | |
GB201913616D0 | Histological image analysis | |
GB201913086D0 | On-body antenna for wireless communication with medical implant | |
WO2020011706A1 | Two chimeric antigen receptors specifically binding cd19 and igkappa | |
EP3711772A1 | Recombinant proteins and fusion proteins | |
GB201901368D0 | Cancer therapy | |
GB201820895D0 | Therapy | |
WO2019020648A1 | Immunotoxins for use in treating cancer | |
WO2018234872A1 | Diagnosis and treatment of cancer | |
GB201810071D0 | Compounds | |
WO2018203145A1 | Systems and methods for monitoring biological fluids | |
GB201804724D0 | Method of diagnosing cceliac disease | |
EP3692058A1 | Chimeric antigen receptors | |
GB201803178D0 | Specific binding molecules for htert | |
GB201800820D0 | Medical implant with wireless communication |